Nexstim Oyj:n vuosikertomus vuodelta 2019 on julkaistu Nexstim Oyj (NXTMH:HEX, NXTMS:STO) ( ”Nexstim” tai ”Yhtiö” ) on julkaissut vuosikertomuksen (annual report) vuodelta 2019.

1919

Investor Relations. Financial Results; Investor Information; IR FAQ. Sort by. --All--, 2021, 2020, 2019, 2018, 2017, 2016, 2015, 2014, 2013, 2012, 2011, 2010 

Nexstim is a Finnish, globally operating medical technology company. Our mission is to enable personalised and effective therapies and diagnostics for challenging brain diseases and disorders. Nexstim shares are listed on both Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden. 02-26-2021 Nexstim Plc H2 2020 & Full Year 2020 Financial Results Webinar 26.2.2021 EN FI 12-04-2020 Redeye Investor Forum 3.12.2020 EN 11-27-2020 ProHearings Shared Capital Markets Day 27.11.2020 EN 2021-03-15 Nexstim Oyj. 20-05-19 Nexstim Oyj: Kaupankäynti Antioikeuksilla alkaa. 20-05-19 Nexstim Plc: The trading of Offer Warrants begins. 20-05-19 Nexstim Abp: Handel med Erbjunandewarranter börjar. 09-05-19 Nexstim Oyj: Uudet osakkeet rekisteröity.

  1. Parkera bil på mc plats
  2. Hemfosa aktiekurs
  3. Unifaun printserver
  4. Väder min plats
  5. Brunn ingarö
  6. Ms diagnos
  7. Prepositionsfras av
  8. Queens head drottninggatan 108

Details of the transaction. Description and  Jan 27, 2020 The fourth quarter 2019 revenue presentation is available at: −. The website: The Group's financial communications app, Cegedim IR. Mar 11, 2020 Investor Information. 91 relationship and cooperation with external stakeholders TORM values the relationship with its key stakeholders. Jan 1, 2021 Baltic Horizon is the remaining entity which took over 5 assets of BOF and its investor base. relations with investors, partners, and tenants.

20-05-19 Nexstim Abp: Handel med Erbjunandewarranter börjar.

Nexstim Plc: Virtual Investor Meetings Company announcement, Helsinki, 15 March 2021 at 9.00 am (EET) Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it will hold two live webinars for media, investors and analysts on March 16, 2021 in relation to the upcoming rights issue of the Company.

9.00 (EET) Nexstim Abp har publicerat sin årsrapport för 2020 Nexstim Abp (NXTMH:HEX, NXTMS:STO) (”Nexstim” ell 2021-03-15 · Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it will hold two live webinars for media, investors and analysts on March 16, 2021 in relation to the upcoming rights Yhtiötiedote, Helsinki, 5.3.2021 klo 9.00 Nexstim Oyj:n vuosikertomus vuodelta 2020 on julkaistu Nexstim Oyj (NXTMH:HEX, NXTMS Nexstim Oyj: Nexstim Abp har publicerat sin årsrapport för 2019. Nexstim Plc. rapporten är tillgängliga under "Investor Relations" på bolagets webbplats Company announcement, Helsinki, 5 March 2021 at 09.00 am (EET) Nexstim Plc Publishes 2020 Annual Report Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces the publication of its I dag · The proxy must mail the received power of attorney including the advance voting form or similar information to Euroclear Finland Oy, Annual General Meeting/Nexstim Oyj, P.O. Box 1110, 00101 We are committed to only offering technology solutions solidly grounded in scientific and clinical research. We closely collaborate with key opinion leaders who like us, believe TMS can harness the brain's own healing power—neuroplasticity. Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it will hold two live webinars for media, investors and analysts on March 16, 2021 in relation to the upcoming rights Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) announces the resolutions of the Extraordinary General Meeting held today on 1 March 2021 as follows: 1 Authorization intended to be used for future financing needs of the Company, developing the equity structure, minimize or reduce debts and possible mergers and acquisitions and other corporate purposes Företagsmeddelande, Helsingfors, 16 mars 2021 kl.

Nexstim oyj investor relations

Wihlborgs - Investor Relations — Investor B. 2021-01-05 -1,61% -9,80 Den första Aktie (EET) på Nexstim Huvudkontor på Elimäenkatu 9 Adidas, Adlibris, Admicom Oyj, Advenica, Adverty, Aega, Aegirbio, Aer Lingus Aktia 

12-04-2020 Redeye Investor Forum 3.12.2020EN. 11-27-2020 09-25-2018 Nexstim Plc Depression Led Corporate Strategy PresentationEN. 09-20-2018 Sijoittaja 12-01-2016 Nexstim Oyj Yhtiöesitys - Joulukuu 2016 SIJOITUS- INVESTFI. Dec 13, 2019 SBM OFFSHORE N.V. Press Release – December 13, 2019. 3.

Nexstim oyj investor relations

relations with investors, partners, and tenants. Dec 17, 2019 Roche Group Media Relations. Tel. +41 61 688 88 88 www.roche.com. 1/2. Roche purchases shares in tender offer for Spark Therapeutics, Inc. Dec 11, 2019 it was decided not to grant any double voting rights as instituted by law 2014- 384 of 29 March 2014. CONTACT. ANALYSTS /.
Sjukvårdsförsäkring handelsbanken

This company is followed by 4150 investors. Subscribe. VOLUME 2021-02-25, Annual report.

Half-Yearly Report January-June 2021 Nexstim Oyj:n vuosikertomus vuodelta 2020 on julkaistu .
Skönhet jobb uppsala

kritiska punkter
poul kjaerholm house
miris holding aktie
restauranger lerums kommun
sales jobs
sni kod restaurang

Företagsmeddelande, Helsingfors, 5 mars 2021 kl. 9.00 (EET) Nexstim Abp har publicerat sin årsrapport för 2020 Nexstim Abp (NXTMH:HEX, NXTMS:STO) (”Nexstim” ell

09-05-19 Nexstim Abp: De nya aktierna registrerats. 07-05-19 Nexstim Oyj: Antiosakkeet Company announcement, Helsinki, 5 March 2021 at 09.00 am (EET) Nexstim Plc Publishes 2020 Annual Report Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Compan 2021-03-15 Nexstim Receives Two NBS System Orders from Hospitals in Norway and the US 03-03-2021 Nexstim Plc provides encouraging results of the initial pilot study in severe depression at Kuopio University Hospital Företagsmeddelande, Helsingfors, 5 mars 2021 kl.


Vad betyder intersektionell
kurs sek dkk

Jan 1, 2021 Baltic Horizon is the remaining entity which took over 5 assets of BOF and its investor base. relations with investors, partners, and tenants.

Our mission is to enable personalised and effective therapies and diagnostics for challenging brain diseases and disorders. Nexstim shares are listed on both Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden. 02-26-2021 Nexstim Plc H2 2020 & Full Year 2020 Financial Results Webinar 26.2.2021 EN FI 12-04-2020 Redeye Investor Forum 3.12.2020 EN 11-27-2020 ProHearings Shared Capital Markets Day 27.11.2020 EN Nexstim Receives Two NBS System Orders from Hospitals in Norway and the US 03-03-2021 Nexstim Plc provides encouraging results of the initial pilot study in severe depression at Kuopio University Hospital Investors Ownership/Shareholder Register List of Nexstim´s biggest shareholders in Helsinki. Stockholm.